Concepedia

Mike Mortimore

MM

Statistics

Publications

4

Citations

240

H-Index

4

Active since

2003

Affiliations

AstraZeneca (United Kingdom)(Current)

Vertex Pharmaceuticals (United Kingdom)

Loughborough University

Mike Mortimore is an author at AstraZeneca (United Kingdom) specializing in medicinal chemistry, heterocycle synthesis, and natural sciences.

Publications per year

2003–2019

4

Publications

4

Hit-to-Lead studies: The discovery of potent adamantane amide P2X7 receptor antagonists

Andrew Baxter, Janice Bent, Keith Bowers et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 120 citations · Full text

, , +16

Hit-to-Lead studies: The discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists

Andrew Baxter, Colin Bennion, Janice Bent et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 46 citations · Full text

, , +14

Enantio‐ and Diastereoselective Suzuki–Miyaura Coupling with Racemic Bicycles

F. Wieland Goetzke, Mike Mortimore, Stephen P. Fletcher · Angewandte Chemie International Edition · 2019 · 39 citations · Full text

, , +15

Formation of quaternary centres by copper catalysed asymmetric conjugate addition to β-substituted cyclopentenones with the aid of a quantitative structure–selectivity relationship

Ruchuta Ardkhean, Mike Mortimore, Robert S. Paton et al. · Chemical Science · 2018 · 35 citations · Full text

, , +12

1–4 of 4